What are Pharvaris' key aims?

Pharvaris aims to provide freedom from angioedema symptoms and attacks, freedom from injections, and injection-like efficacy with placebo-like tolerability in an oral pill for people living with HAE.

What is Pharvaris' expertise?

Pharvaris is a leader in bradykinin-mediated diseases and is committed to improving the treatment of HAE and the quality of life for people living with the condition.

How does Pharvaris prioritize the HAE community?

Pharvaris' legacy in HAE, scientific expertise, and values drive their passion to provide choice and effective, safe, and easy-to-administer therapies for people living with HAE.

Voyager DB

Deep data on millions of local businesses, with verified decision-makers to reveal.

Contact Research

Hand-built prospect lists from human researchers, delivered in 24 hours.

People Search

Find owners and decision-makers by job title, seniority and department.

Chrome Extension

Coldlytics in your browser - prospect any business as you browse the web.

Integrations

Instantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

Voyager DBDeep data on millions of local businesses, with verified decision-makers to reveal.Contact ResearchHand-built prospect lists from human researchers, delivered in 24 hours.People SearchFind owners and decision-makers by job title, seniority and department.Chrome ExtensionColdlytics in your browser - prospect any business as you browse the web.IntegrationsInstantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

PricingPricing AgenciesAgencies BlogBlog

LoginLogin

Pharvaris

$6.0M revenue • 40 employees • United States

Last Updated May 8, 2025

Own this business? Claim & update this listing →

Company Overview

Company Name

Pharvaris

Address

United States

Website

pharvaris.com

Approx. Annual Revenue

$6.0M

Employees

Established

2010

About Pharvaris

Pharvaris is a late-stage biopharma company based in the United States, focused on developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. The company aims to provide effective, safe, and easy-to-administer therapies that improve the standard of care for people living with HAE.

Business Profile

Read from the Pharvaris website on Oct 14, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed): 8/10 · Current copyright 2026; Complete navigation and content
Footer copyright year: 2026

Pharvaris is hiring

Open roles listed on their website as of Oct 14, 2026.

Scientific Publications Lead Medical Affairs
Congress and Peer-to-Peer Lead U.S. Commercial
Care Specialists U.S. Commercial, Market Access
Supply Chain Operations Lead Technical Operations, Global Supply Chain
Senior Lead Quality Operations & Compliance (GxP) Global QA
Corporate Compliance Lead Legal and Compliance

Hiring in: Management, Engineering & IT

View careers page →

Recent changes

What changed on the Pharvaris website and Google listing, as detected by Coldlytics on each visit.

Oct 14, 2026
Started advertising open roles
Scientific Publications Lead Medical Affairs, Congress and Peer-to-Peer Lead U.S. Commercial, Care Specialists U.S. Commercial, Market Access
Oct 14, 2026
Estimated revenue band moved from $500K-1M to $5M-10M
Oct 14, 2026
Estimated headcount moved from 2-5 to 21-50 employees
Oct 14, 2026
Google Ads pixel installed

Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.

Find companies by what just changed →

Biotech & Life Sciences Companies near CA

Browse all Biotech & Life Sciences companies in California →

Frequently Asked Questions about Pharvaris

Advertising Pixels

Facebook Ad Pixel
Google Ad Pixel
LinkedIn Ad Pixel

Technologies Used

Social Profiles

Key Decision Makers

Aimee Sundberg Executive Director, Clinical Development Lead

Justin Sun Clinical Trial Manager

Meagen St. Louis Clinical Trial Manager